Albuquerque, Cícero Piva de; Freitas, Fatima R; Martinelli, Ana Elisa M; Lima, Josefa H; Coelho, Rafael F; Serrano Jr., Carlos V; Nahas, Willian Carlos 
; Kalil Filho, Roberto ; Maranhão, Raul Cavalcante
Source: Lipids in Health and Disease. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS, NEOPLASIAS PROSTÁTICAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBUQUERQUE, Cícero Piva de et al. Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma. Lipids in Health and Disease, v. 19, 2020Tradução . . Disponível em: https://doi.org/10.1186/s12944-020-01305-8. Acesso em: 12 nov. 2024.APA
Albuquerque, C. P. de, Freitas, F. R., Martinelli, A. E. M., Lima, J. H., Coelho, R. F., Serrano Jr., C. V., et al. (2020). Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma. Lipids in Health and Disease, 19. doi:10.1186/s12944-020-01305-8NLM
Albuquerque CP de, Freitas FR, Martinelli AEM, Lima JH, Coelho RF, Serrano Jr. CV, Nahas WC, Kalil Filho R, Maranhão RC. Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma [Internet]. Lipids in Health and Disease. 2020 ; 19[citado 2024 nov. 12 ] Available from: https://doi.org/10.1186/s12944-020-01305-8Vancouver
Albuquerque CP de, Freitas FR, Martinelli AEM, Lima JH, Coelho RF, Serrano Jr. CV, Nahas WC, Kalil Filho R, Maranhão RC. Androgen deprivation therapy improves the in vitro capacity of high-density lipoprotein (HDL) to receive cholesterol and other lipids in patients with prostate carcinoma [Internet]. Lipids in Health and Disease. 2020 ; 19[citado 2024 nov. 12 ] Available from: https://doi.org/10.1186/s12944-020-01305-8
